"I thought I was too young to have cancer," Alexis Klimpl told Newsweek, adding: " "In my eyes, my breasts betrayed me." ...

How many, if any, cases of nervous system disorders have been reported because of A-C breast cancer chemotherapy? I'm 45 and had treatment at 39 and 40. I now experience a very exaggerated amount of ...

UFC CEO Dana White brought it to notice that Jon Jones was retiring in the last month. The former UFC The post Jon Jones Lauded for ‘Finest’ Social Media Spark Since UFC Retirement U-Turn by Outspoken ...

The therapeutic landscape for hormone receptor-positive (HR+) advanced breast cancer (BC) is moving from generalized ...

ProPublica spent 14 months investigating the FDA’s oversight of foreign drugmakers that send medications to the U.S. These are the key takeaways.

A novel medication out of Sweden has shown some of the same promise in melting belly fat — without making your stomach churn.

The purpose of these estimates is to inform state and local cancer care organizations and providers, patient support programs and educators, advocates, and researchers so they can allocate resources ...

Amycretin, a new weight-loss treatment from Novo Nordisk, combines two hunger hormones, helping participants lose nearly one-quarter of their body weight in early trials.

Trump’s most-favored-nation executive order would collapse the American pharmaceutical industry’s innovation edge.

A new study suggests that a medication in the same family as Ozempic could cut the number of days people suffer from migraines by more than half.

How a fugitive drug lord wanted by the U.S. was captured in his bunker A year and a half after his prison escape, José Adolfo “Fito” Macías Villamar was found hiding in a secret basement in ...

Novo Nordisk on Friday said full results from early-stage trials show that its experimental drug, amycretin, helped overweight and obese adults lose up to 24% of their weight as the Danish company ...